Using Post-Priority Evidence To Demonstrate Lack Of Invention

The Court of Appeal has today handed down an important decision in Generics [UK] Limited t/a Mylan ("Mylan") v Yeda Research & Development Co Ltd ("Yeda") & Teva Pharmaceuticals Industries Ltd [2013] EWCA Civ 925. It concerns Yeda's patent for a synthetic copolymer known as copolymer-1. Mylan had sought revocation of the patent and a declaration of non-infringement of their product, copaxone.

The first instance decision that the patent is valid and refusing the declaration of...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT